Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

Chief R&D Officer

VP Operations

Chief Innovation Officer

EVP & Chief Financial Officer

VP Peripheral Nerve Science

Chief Human Resources Officer

General Counsel and CCO

AxoGen, Inc., together with its subsidiaries, develops and markets technologies for peripheral nerve regeneration and repair worldwide. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; and AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments. Its products also comprise Axoguard Nerve Cap, a porcine submucosa ECM product that is used to protect a peripheral nerve end, as well as separates the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma; and AxoTouch two-point discriminator, a tool that is used for measuring the innervation density of surface area of the skin. The company provides its products to hospitals, surgery centers, and military hospitals, plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons. AxoGen, Inc. is headquartered in Alachua, Florida.

AxoGen, Inc., together with its subsidiaries, develops and markets technologies for peripheral nerve regeneration and repair worldwide.

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-03-21	Premium	acquired	Premium	Premium	Premium	Chief R&D Officer
2024-03-21	Premium	sold	Premium	Premium	Premium	VP Operations
2024-03-21	Premium	sold	Premium	Premium	Premium	Chief Innovation Officer
2024-03-21	Premium	sold	Premium	Premium	Premium	CEO
2024-03-21	Premium	sold	Premium	Premium	Premium	Chief R&D Officer
2024-03-16	Premium	acquired	Premium	Premium	Premium	Chief Innovation Officer
2024-03-16	Premium	acquired	Premium	Premium	Premium	VP Operations
2024-03-16	Premium	acquired	Premium	Premium	Premium	CEO
2024-03-16	Premium	acquired	Premium	Premium	Premium	Chief R&D Officer
2024-03-07	Premium	sold	Premium	Premium	Premium	VP Operations
2024-03-07	Premium	sold	Premium	Premium	Premium	-
2024-03-01	Premium	acquired	Premium	Premium	Premium	Chief Innovation Officer
2024-01-01	Premium	acquired	Premium	Premium	Premium	CFO
2023-12-11	Premium	sold	Premium	Premium	Premium	EVP & Chief Financial Officer
2023-10-13	Premium	back to issuer	Premium	Premium	Premium	VP Operations
2023-10-13	Premium	back to issuer	Premium	Premium	Premium	EVP & Chief Financial Officer
2023-10-13	Premium	back to issuer	Premium	Premium	Premium	VP Peripheral Nerve Science
2023-10-13	Premium	back to issuer	Premium	Premium	Premium	Chief R&D Officer
2023-10-13	Premium	back to issuer	Premium	Premium	Premium	Chief Human Resources Officer
2023-09-06	Premium	bought	Premium	Premium	Premium	-
2023-08-24	Premium	acquired	Premium	Premium	Premium	-
2023-08-23	Premium	bought	Premium	Premium	Premium	-
2023-08-16	Premium	bought	Premium	Premium	Premium	-
2023-07-18	Premium	acquired	Premium	Premium	Premium	VP Peripheral Nerve Science
2023-07-18	Premium	acquired	Premium	Premium	Premium	EVP & Chief Financial Officer

AXGN - AxoGen Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for AXGN